|
LACTB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07067696322838E-12 |
| Normal-vs-Stage2 |
2.795000E-04 |
| Normal-vs-Stage3 |
2.10659999999585E-05 |
| Normal-vs-Stage4 |
9.958100E-03 |
| Stage1-vs-Stage2 |
4.239200E-01 |
| Stage1-vs-Stage3 |
3.916000E-01 |
| Stage1-vs-Stage4 |
7.438200E-01 |
| Stage2-vs-Stage3 |
2.167400E-01 |
| Stage2-vs-Stage4 |
8.146600E-01 |
| Stage3-vs-Stage4 |
3.827400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.96819999970432E-07 |
| Normal-vs-Asian |
1.759770E-01 |
| Caucasian-vs-AfricanAmerican |
2.370400E-01 |
| Caucasian-vs-Asian |
8.364400E-01 |
| AfricanAmerican-vs-Asian |
5.504000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.3378999999556E-06 |
| Male-vs-Female |
1.039700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.426800E-04 |
| Normal-vs-Extreme_Weight |
5.24740251250932E-11 |
| Normal-vs-Obese |
2.90440005379367E-09 |
| Normal-vs-Extreme_Obese |
1.153990E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.329810E-01 |
| Normal_Weight-vs-Obese |
1.082960E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.398790E-01 |
| Extreme_Weight-vs-Obese |
7.881600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.491000E-01 |
| Obese-vs-Extreme_Obese |
5.613600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.606900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62669877568078E-12 |
| Normal-vs-Age(61-80Yrs) |
8.72224514836262E-12 |
| Normal-vs-Age(81-100Yrs) |
1.110480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.071500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.830100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.795700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.232100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.806160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.780000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
8.06660005459037E-09 |
| Normal-VS-KIRP CIMP |
9.018700E-03 |
| Normal-VS-Unclassified PRCC |
3.71710000000025E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.793600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.555600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.630800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.801200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.362000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.386000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03309999946555E-07 |
| Normal-vs-N1 |
1.58108999999129E-05 |
| Normal-vs-N2 |
4.638400E-01 |
| N0-vs-N1 |
6.999800E-01 |
| N0-vs-N2 |
2.598000E-01 |
| N1-vs-N2 |
1.408230E-01 |
|
|
